|
The Role of Oraverse (Phentolamine Mesylate) in Dental Practice
|
Presenter: Dr. Sean Boynes
|
Release Date: 10/25/12
|
|
Credits: 1 CEU, Free Self-Study
|
Expiration Date: 10/25/27
|
|
AGD Subject Code: 730
|
Reviewed: 2024
|
|
This CE webinar will provide a comprehensive review of the pharmacology, efficacy, and safety of Oraverse. Since its FDA approval in 2008, Oraverse has been increasingly used in dental practice. There exists variation between dental providers on how it is marketed and used during the daily course of comprehensive dental care delivery. Using evidence based information including the introduction of a new study evaluating its real world use, the presentation will analyze and describe phentolamine mesylate’s role in current dental practice.
Upon completion of this CE webinar, the student will be able to: be familiarized with the pharmacology, efficacy, and safety of Oraverse and better understand its role in current dental practice.
( disclaimer
, AGD PACE Statement
)
|
 |
View Class
|
|
Click the arrow to view the training material.
 Desktop and Mobile Compatible
|
Take CE Exam |
|
To earn CE credit you must pass the CE exam.
|
Class Notes |
|
You must be logged in to take notes for this class.
|
